| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07476326 Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as… |
Trial sites expanded: 26 -> 48 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07299955 | A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and… | Healthy Male Participants | Recruiting |
| NCT07581509 | Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant… | Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings) | Not Yet Recruiting |
| NCT07476326 | Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as… | Melanoma | Not Yet Recruiting |